Thermo Fisher Scientific completed the acquisition of Clario from Partners Group.

Thermo Fisher Scientific, a manufacturer of scientific instruments, completed the acquisition of Clario, a healthcare research technology company, from Partners Group, a global private markets investment manager. Financial terms were not disclosed. “Clario is an outstanding strategic fit, enabling faster, more informed drug development through differentiated technology and data intelligence solutions. At Thermo Fisher, we come to work every day thinking about how we can further advance our customers’ important work, and by adding these high-growth capabilities, we will deliver even deeper clinical insights to our customers and further accelerate the digital transformation of clinical research,” Marc N. Casper, Thermo Fisher Scientific Chairman, President and Chief Executive Officer.